Issued share capital
Shares in issue: 594,117,768 0.1p ordinary shares in issue, as at last close.
Shares held not in public hands: 372,069,867 0.1p ordinary shares, being 62.63% of the issued share capital, as at 30 November 2017.
Shares held in treasury: Nil 0.1p ordinary shares, as at 30 November 2017.
Shares in Allergy Therapeutics plc can be bought or sold through the share dealing services outlined below or by contacting your stockbroker. However, if you sell or dispose of your shares, you may be liable for capital gains tax. It is therefore recommended that you seek independent professional advice on the consequences of selling or disposing of shares yourself.
Share Dealing Services Available
By telephone: +44 1903 844700
Online: To contact Allergy Therapeutics, please click here.
Private and corporate shareholders can advise of a change of address by post:
Click here to download the Change of Address Form
Shareholders can also transfer shares to another person:
Click here to download the Stock Transfer Form
Warning to Shareholders
Allergy Therapeutics is aware that there are a number of share scams in operation and warns shareholders to be cautious when dealing with their shares. The Company would like to draw shareholders’ attention to the advice given by the FCA on this subject. Please click here to visit their website for further information and advice.